UK Life Sciences Market Entry
Virtual 1-2-1 Connector Workshop
Meet HealthTech & Healthcare Experts from Around the UK
16th May 2024 / 9:00 -12:00 BST
Organiser
GTM Global
When
16th May 2024
09:00 - 12:00 BST
Where
Online Zoom
Cost
£99 per company
Payment details provided upon acceptance
Format
Market Entry briefings
Followed by 1-2-1 advisory sessions
Access a £108 billion UK Life Sciences market without leaving your office chair!
With a13% increase in turnover value generated in the UK life sciences market from £96 billion to £108 billion in 2023, the UK is the perfect launch pad for ambitious European med-tech, digital health, pharma, biopharma, CRO and academic companies to land and expand into. Success in the UK also is often a platform to expand into the US.
GTM Global is hosting a suite of Virtual Market Entry Life Sciences Workshops for European Health-tech and Healthcare scale-up companies, where from the comfort of your own office chair – you can find out how to land and expand into this lucrative and fast growing UK market.
On registration, a member of the GTM team will speak with you directly and qualify your UK market entry plans. We'll identify with you a roadmap for UK expansion. We'll then directly connect you to a suite of 1-2-1 virtual sessions with UK experts in the NHS, academia, business development, funding and compliance.
Imagine the huge value of having these qualified virtual sessions on UK market entry, without the costs of flights, time and accommodation!
Why Attend This Event
Event Advisors
Mark Stimpfig
Co Founder GTM GlobalProviding advice & guidance for tech and digital scale up brands to expand internationally & support companies looking to land & expand into the Greater Phoenix region USA
Chris Howie
Director of Life Sciences, GTM GlobalChris has over 30 years of experience in key sectors such as MedTech devices, Pharma, Bio Pharma, CRO and Academia. He has great access to mission-critical clinical trial and evaluator channels as well as funding, investment, government, and regulatory bodies and networks.
Mark Treherne
Commercial Research Scientist30 years of experience in the discovery & diagnosis of novel treatments for diseases with unmet medical needs. Formerly at Pfizer, doing research into neurodegenerative diseases in the UK. Subsequently, set up Cambridge Drug Discovery in 1997 and sold it in 2001. Since then, helped to raise £300mln for life sciences companies, and enabled inward investment into the UK of £6bln.
Keith Miller
Life-Science Strategy ConsultantLife Science Specialist with a track record of delivery in both industry and private sector roles. Consultancies and interims have included, Department for International Trade, Northern Health Science Alliance, MedCity, US Pharma and Molecular Pathology Laboratory Network Inc and West Midlands Growth Company.
Markus Hauser
Head of Inward Investment, British Embassy ViennaMarkus supports Austrian companies succeeding in the UK. He has strong experience in International Trade Promotion and FDI, Trade Policy work, and Business Development as well as intercultural experiences from living in Sweden and Israel, and dealing with projects in the UK and the Middle East.
Tony Young
National Clinical Lead for Innovation, NHS EnglandTony provides national-level leadership for innovation for the NHS in England. He advises government ministers, civil servants across government, NHS England, other arm’s length bodies, charities, UK and global industry, foreign governments and organisations on innovation in healthcare.
Christina Pecoraro
Account Manager, QRx PartnersBringing over a decade of experience, Christina has been employed in quality assurance, medical device regulatory affairs, and business development. She gets involved in supporting all sizes of medical device companies such as Boston Scientific and Medtronic, to small startups.
Mark Swanson
Healthcare Regulatory Advisor, QRx PartnersMark has been a leader in Quality and Regulatory for over 25 years. His career includes roles in quality engineering, design assurance, audit, and quality management for companies, including St. Jude Medical and Medtronic, and has provided guidance to numerous medical device and pharmaceutical manufacturers of all sizes.
Helen Stubbs
DBT Senior Inward Investment Officer, British Embassy BerneHelen is working to promote inward investment into the UK and bilateral UK-Swiss relations from within DBT at the British Embassy in Berne. In particular, supporting Swiss companies in the life sciences, agrifood and space sectors to establish a UK presence and to grow their UK activities.
Martin Shiderov
Associate Director, Akeso & CompanyMartin is an Associate Director at Akeso & Company, an independent and dynamic management consultancy specialising in delivering operational improvements across the Healthcare and Life Science industry. They help companies achieve their goals through expert consulting, analytics and managed service support.
Malcolm Joy
Lead Partner, Frazier & Deeter UK LLPMalcolm is the Lead Partner of Frazier & Deeter UK, a firm providing advisory services to mid-market businesses, with expertise in supporting cross-border businesses. In addition to leading the firm’s growth in the UK, Malcolm is responsible for tax advisory services and transaction advisory services. Malcolm is also the Global Leader of Transfer Pricing Services at Frazier & Deeter.
Thomas Wells
Senior Manager - R&D, Frazier & Deeter UK LLPThomas is a Senior Manager - R&D at Frazier & Deeter UK, a firm providing advisory services to mid-market businesses, with expertise in supporting cross-border businesses.
Mindy Daeschner
E-health Practitioner, Daeschner ConsultingMindy is an E-health Practitioner, offering consulting services, commercial strategy, problem solving and storytelling for businesses focused on transformation of healthcare provision, delivery of technology products, services and exit strategies.
Rocco Mogno
Director - Head of Commercial, Interpolitan MoneyRocco is a Head of Commercial at Interpolitan Money, providing global alternative banking solutions for Private, Corporate, Funds & Institutions and Non-Resident services.
Jon East
Director - Head of Marketing, Interpolitan MoneyJon is Head of Marketing at Interpolitan Money, providing global alternative banking solutions for Private, Corporate, Funds & Institutions and Non-Resident services.
Rachel Scott
Head of Life Sciences Germany, British Consulate General DüsseldorfRachel is a Head of Life Sciences Germany at the British Consulate General Düsseldorf, assisting German companies to bring their high-quality investment to the UK.
Juan R. Garcia
Chairman of the Board, Biotechnology Business InstituteJuan is a Chairman of the Board at the Biotechnology Business Institute, an international academic institution in management focus in life sciences and healthcare.
Natalie Thomas
Head of Swiss Business Hub UK + IrelandNatalie is a Head of Swiss Business Hub UK + Ireland, part of the Swiss Embassy in London. The Swiss Business Hub United Kingdom & Ireland represents Switzerland Global Enterprise (S-GE). S-GE supports entrepreneurs and promotes Switzerland as a business location.
Dave Olson
Managing Partner, MedTech BridgeDave is an experienced MedTech executive and entrepreneur with broad knowledge of the Minnesota startup environment. As a Managing Partner at MedTech Bridge, Dave helps Nordic and European MedTech companies gain market access and commercialisation in the US Market.
Tim Damgaard Christensen
Managing Partner, MedTech BridgeTim has an engineering background, and a 24+ year-long career in the MedTech industry within hardware and software development, project management, program management, and product development. This includes all aspects of MedTech product development from the earliest innovation and ideation phases to phase-out and taking products off markets globally.